Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit

Details for Australian Patent Application No. 2006325404 (hide)

Owner Cipla Limited

Inventors Malhotra, Geena; Lulla, Amar

Agent Griffith Hack

Pub. Number AU-B-2006325404

PCT Pub. Number WO2007/068934

Priority 1566/MUM/2005 14.12.05 IN; 1878/MUM/2006 13.11.06 IN

Filing date 14 December 2006

Wipo publication date 21 June 2007

Acceptance publication date 1 March 2012

International Classifications

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/536 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems

A61K 31/5513 (2006.01)

A61K 31/7068 (2006.01)

A61K 31/7072 (2006.01)

A61K 31/7076 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/068934 Priority application(s): WO2007/068934

1 March 2012 Application Accepted

  Published as AU-B-2006325404

28 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006325408-Antimicrobial composition

2006325401-A dispensing device